Fresenius Kabi USA, LLC Recall: Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL f
Fresenius Kabi USA, LLC Recall: Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL f is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Fresenius Kabi USA, LLC; Product: Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Frese
| Recalling firm | Fresenius Kabi USA, LLC |
|---|---|
| Product | Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Fresenius Kabi USA 2020 N Ruby Street, Melrose Park, IL 60160-1112 for Fresenius Kabi USA, 3 Corporate Dr Lake Zurich, IL 60047-8930. NDC 63323-614-01 |
| Reason for recall | Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016) |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20150728 |
| Recall number | D-1327-2015 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →